Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can androgen deprivation be considered a primary treatment for prostate cancer?

Nature Clinical Practice Urology volume 3, pages 126–127 (2006)Cite this article

boxed-textJanoff DM et al. (2005) Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer. BJU Int 96: 503–507

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Brawer MK et al. (2001) Perspectives on prostate cancer diagnosis and treatment: a roundtable. Urology 58: 135–140

    Article  CAS  Google Scholar 

  2. Kirk D (2004) Timing and choice of androgen ablation. Prostate Cancer Prostatic Dis 7: 217–222

    Article  CAS  Google Scholar 

  3. The Medical Research Council Prostate Cancer Working Party Investigators Group (1997) Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Br J Urol 79: 235–246

  4. Studer UE et al. (2005) Patients with symptomatic prostate cancer T.0-4 N.0-2 M.0 not suitable for local definitive treatment: do they need immediate androgen deprivation? Eur Urol Suppl 4: 78

    Article  Google Scholar 

  5. Daniell HW (1997) Osteoporosis after orchiectomy for prostate cancer. J Urol 157: 439–444

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Consultant Urologist at Gartnavel General Hospital, Glasgow, UK

    David Kirk

  2. Honorary Professor at Glasgow University,

    David Kirk

Authors
  1. David Kirk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Kirk.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirk, D. Can androgen deprivation be considered a primary treatment for prostate cancer?. Nat Rev Urol 3, 126–127 (2006). https://doi.org/10.1038/ncpuro0428

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0428

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing